Synaptogenix raises $5M via Series C Convertible Preferred and warrants

TAO Synergies Inc.

Closed private placement of Series C Preferred (convertible at $4/share) and warrants for aggregate gross proceeds of $5M.
Preferred carries 5% annual cash dividend, 107% quarterly amortization redemption starting Oct 31, 2024.
Company must seek stockholder approval by Dec 31, 2024 to issue more than 19.99% of common stock upon conversion.
Holders can force cash redemption after first anniversary; Triggering Events include failure to register shares.
Covenants restrict indebtedness, liens, acquisitions, dividends, and asset transfers.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.